Social Behavior: Clinical Trials

9 trials for Social Behavior, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 unknown. 9 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 19Unknown 9
Phase 25Unknown 5

Follow Social Behavior: new trials by email Literature Review of Social Behavior trials Research Report on Social Behavior

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Protecting Alzheimer Caregivers Using Technology Through Staying Sharp
Staying Sharp intervention - Mild Cognitive Impairment, Dementia Alzheimers
Phase 1 / Phase 2UnknownOregon Health and Science University1382023-04-302023-02-09
The Effect of LSD on Neural Synchrony, Prosocial Behavior, and Relationship Quality
LSD, Ethanol - Prosocial Behavior
Phase 1 / Phase 2UnknownMaastricht University602023-01-012023-01-04
DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation
Triptorelin 3.75 MG Injection, Transvaginal oocyte retrieval, Triptorelin Injection - Breast Cancer Female
Phase 1 / Phase 2UnknownUniversitair Ziekenhuis Brussel302022-11-012023-05-18
Adipose Derived Mesenchymal Cell Treatment in Lungtransplantation
adipose derived mesenchymal stromal cells, Saline - Lung Transplant Rejection
Phase 1 / Phase 2UnknownCopenhagen University Hospital, Rigshospitalet302020-10-012021-07-16
Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients
Envarsus, Tacrolimus - Kidney Transplant; Complications, Kidney Transplant Failure and Rejection
Phase 1UnknownCalifornia Institute of Renal Research502018-07-112023-02-09
Neurokinin (NK) 1 Antagonist for Pathological Aggression for Harmful, Impulsive, and Self-/Aggressive Behaviour
NK1 Antagonist, Placebo Oral Capsule - Aggression
Phase 1 / Phase 2UnknownSt. Joseph's Healthcare Hamilton502017-01-012019-04-22
Safety Study of Using Regulatory T Cells Induce Liver Transplantation Tolerance
Regulatory T cells - Chronic Rejection of Liver Transplant
Phase 1UnknownNanjing Medical University12014-12-012015-02-24
Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance
Conventional plus UC-MSC, Conventional plus placebo - Evidence of Liver Transplantation
Phase 1UnknownBeijing 302 Hospital502012-02-012013-05-31
Research Study of Nutritional Methods to Reduce Body Fat Percentages in Overweight and Obese Populations
Non-Personalized Meal Planning, Personalized Meal Planning and Dietetic Consultation - Obesity
Phase 1UnknownCentral FITT, Inc322007-06-012007-07-03

Narrower conditions

Rejection, Psychology (4)  ·  Helping Behavior (2)  ·  Aggression (1)  ·  Altruism (1)  ·  Alzheimer Disease (1)  ·  Caregiver Burden (1)  ·  Cognitive Dysfunction (1)  ·  Health Behavior (1)  ·  Obesity (1)  ·  Overweight (1)  ·  Platelet Glycoprotein IV Deficiency (1)  ·  Weight Loss (1)

Broader conditions

Behavior (9)  ·  Behavioral Symptoms (2)  ·  Aberrant Motor Behavior in Dementia (1)  ·  Body Weight (1)  ·  Body Weight Changes (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cognition Disorders (1)  ·  Dementia (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurocognitive Disorders (1)  ·  Neurodegenerative Diseases (1)  ·  Nutrition Disorders (1)

Interventions

Sodium Chloride (2)  ·  Congresses as Topic (1)  ·  Ethanol (1)  ·  Immunosuppressive Agents (1)  ·  Injections (1)  ·  Lysergic Acid Diethylamide (1)  ·  Tacrolimus (1)  ·  Triptorelin Pamoate (1)

Sponsors

Beijing 302 Hospital (1)  ·  California Institute of Renal Research (1)  ·  Central FITT, Inc (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Maastricht University (1)  ·  Nanjing Medical University (1)  ·  Oregon Health and Science University (1)  ·  St. Joseph's Healthcare Hamilton (1)  ·  Universitair Ziekenhuis Brussel (1)

Countries

China (2)  ·  United States (2)  ·  Belgium (1)  ·  Canada (1)  ·  Denmark (1)  ·  Netherlands (1)

Top investigators

Anahita Mistry, PhD (1)  ·  Arman Faravardeh, MD (1)  ·  Chao-Yi Wu, PhD (1)  ·  Fu-Sheng Wang, PHD (1)  ·  Hong Wang, MD (1)  ·  Jeffrey Kaye, MD (1)  ·  Jens Kastrup, MD Professor (1)  ·  Johannes G Ramaekers, PhD (1)  ·  Judith Brooks, Phd (1)  ·  Michael Perch, MD (1)  ·  Michel De Vos, MD PhD (1)

Results publications

PMID 18468541, PMID 20930086, PMID 21352202, PMID 22320928, PMID 22436957, PMID 40247997

NIH funding

P30AG024978 (1)